M.R. SHAIDULLINA^1,2, A.KH. SHAIMARDANOVA¹

 ¹Republic Сhildren’s Clinical Hospital, Kazan

²Kazan State Medical University, Kazan

 Contact details:

Shaidullina M.R. — PhD (medicine), Associate Professor of the Department of Endocrinology, Head of Endocrinology Unit

Address: 140 Orenburgskiy trakt, Kazan, Russian Federation, 420064, tel.: +7-960-045-67-79, e-mail: zizi97@mail.ru

The review summarizes the information concerning the endocrine system functional state of premature babies. It also analyses the results of studies of thyroid and adrenal glands — the organs that are most important for post-natal life adaptation. An attempt is made to monitor how the influence of endocrine glands functioning on the development of premature babies.

(For citation: Shaidullina M.R., Shaimardanova A.Kh. Thyroid and adrenal functions in babies born with low and extremely low body weight. Practical medicine. 2023. Vol. , № , P.)

REFERENCES

1. Prikaz Ministerstva zdravookhraneniya i sotsial’nogo razvitiya RF ot 27.12.2011 no. 1687n. Meditsinskie kriterii rozhdeniya. S izmeneniyami i dopolneniyami ot 16.01.2013, 13.09.2019 [Order of the Ministry of Health and Social Development of the Russian Federation dated December 27, 2011 No. 1687n. Medical criteria for birth. With changes and additions from 01/16/2013, 09/13/2019].
2. Casavant S.G., Cong X., Fitch R.H., Moore J., Rosenkrantz T., Starkweather A. Allostatic Load and Biomarkers of Stress in the Preterm Infant: An Integrative Review. Biological Research for Nursing, 2019, vol. 21 (2), pp. 210–223. DOI: 10.1177/1099800418824415
3. Sadykov M.N., Gaynutdinov A.R., Khusnullina G.R. Statistika zdorov’ya naseleniya i zdravookhraneniya (po materialam RT za 2016–2020 gg.): uchebno-metodicheskoe posobie [Statistics of population health and healthcare (based on materials from the Republic of Tatarstan for 2016–2020): educational and methodological manual]. Kazan, 2021. 267 p.
4. Minnullin M.M., Sadykov M.N., Sherputovskiy V.G., Khusnullina G.R., Zalyalov R.R. Statistika zdorov’ya naseleniya i zdravookhraneniya (po materialam RT za 2018–2022 gg.): uchebno-metodicheskoe posobie [Statistics of population health and healthcare (based on materials from the Republic of Tatarstan for 2018–2022): educational and methodological manual]. Kazan, 2023. 266 p.
5. Vijay Srinivasan, Jan Hau Lee, Kusum Menon, Jerry J. Zimmerman, Melania M. Endocrine Dysfunction Criteria in Critically Ill Children. The Podium Consensus Conference Pediatrics, 2022, vol. 149 (1), pp. S84–S90. DOI: 10.1542/peds.2021-052888M
6. Caparros-Gonzalez R.A., Romero-Gonzalez B., Gonzalez-Perez R. et al. Maternal and Neonatal Hair Cortisol Levels Are Associated with Infant Neurodevelopment at Six Months of Age. Journal of Clinical Medicine, 2019, vol. 8 (11), p. 2015. DOI: 10.3390/jcm8112015
7. Enlow M.B., Sideridis G., Bollati V., Hoxha M. Wright, Maternal cortisol output in pregnancy and newborn telomere length: Evidence for sex-specific effects. Psychoneuro endocrinology, 2019, vol. 102, pp. 225–235. DOI: 10.1016/j.psyneuen
8. Cho J., Su X., Holditch-Davis D. Associations of Maternal Testosterone and Cortisol Levels with Health Outcomes of Mothers and Their Very-Low-Birthweight Infants. Biological Research For Nursing, 2017, vol. 19 (4), pp. 409–418. DOI: 10.1177/1099800417703704
9. Cho J., Chien L.-C., Holditch-Davis D. Associations Between Hormonal Biomarkers and Preterm Infant Health and Development During the First 2 Years After Birth. Biological Research for Nursing, 2021, vol. 23 (2), pp. 188–197. DOI: 10.1177/1099800420942893
10. al Saedi S., Dean H., Dent W., Cronin C. Reference ranges for serum cortisol and 17-hydroxyprogesterone levels in preterm infants. The Journal of Pediatrics, 1995, vol. 126 (6), pp. 985–987. Doi: 10.1016/S0022-3476(95)70229-6
11. Heckmann M., Wudy S.A., Haack D., Pohlandt F. Reference range for serum cortisol in well preterm infants. Arch Dis Child Fetal Neonatal, 1999, vol. 81, pp. F171–174.
12. Ng S.M., Ogundiya A., Didi M., Turner M.A. Adrenal function of extremely premature infants in the first 5 days after birth. J Pediatr Endocrinol Metab, 2019, vol. 32 (4), pp. 363–367. DOI: 10.1515/jpem-2018-0417
13. Hwang J.H., Lee B.S., Kim C.Y., Jung E., Kim E.A., Kim K.S. Basal serum cortisol concentration in very low birth weight infants. Pediatr Neonatol, 2019, vol. 60 (6), pp. 648–653. DOI: 10.1016/j.pedneo.2019.03.003
14. Renolleau Ch., Toumazi A., Bourmaud A. et al. Association between Baseline Cortisol Serum Concentrations and the Effect of Prophylactic Hydrocortisone in Extremely Preterm Infants. The Journal of Pediatrics, vol. 234, pp. 65–70.
15. Aucott S., Watterberg K., Shaffer M. et al. Early cortisol values and long-term outcomes in extremely low birth weight infants. J Perinatol, 2010, vol. 30, pp. 484–488. DOI: 10.1038/jp.2009.191
16. Shaffer M.L., Baud O., Lacaze-Masmonteil T., Peltoniemi O.M., Bonsante F., Watterberg K.L. Effect of Prophylaxis for Early Adrenal Insufficiency Using Low-Dose Hydrocortisone in Very Preterm Infants: An Individual Patient Data Meta-Analysis. J Pediatr, 2019, vol. 207, pp. 136–142.e5. DOI: 10.1016/j.jpeds.2018.10.004
17. Ramaswamy V.V., Bandyopadhyay T., Nanda D. et al. Assessment of Postnatal Corticosteroids for the Prevention of Bronchopulmonary Dysplasia in Preterm Neonates: A Systematic Review and Network Meta-analysis. JAMA Pediatr, 2021, vol. 175 (6), pp. e206826. DOI: 10.1001/jamapediatrics.2020.6826
18. Baud O., Watterberg K.L. Prophylactic postnatal corticosteroids: early hydrocortisone. Semin Fetal Neonatal Med, 2019, vol. 24, p. 202e6.
19. Peeples E.S., Comstock B.A., Heagerty P.J., Juul S.E. Preterm Erythropoietin Neuroprotection (PENUT) Trial Investigators. Blood pressure values and hypotension management in extremely preterm infants: a multi-center study. J Perinatol, 2022, vol. 42 (9), pp. 1169–1175. DOI: 10.1038/s41372-022-01425-2
20. Suzuki Y., Kono Y., Hayakawa T., Shimozawa H., Matano M., Yada Y. et al. Neonatal factors related to center variation in the incidence of late-onset circulatory collapse in extremely preterm infants. PLoS ONE, 2018, vol. 13 (6), p. e0198518. DOI: 10.1371/journal. pone.0198518
21. Kawai M. Late-onset circulatory collapse of prematurity. Pediatr Int, 2017, vol. 59, pp. 391–396. DOI: 10.1111/ped.13242
22. Shimokaze T., Akaba K., Saito E. Late-Onset Glucocorticoid-Responsive Circulatory Collapse in Preterm Infants: Clinical Characteristics of 14 Patients. The Tohoku Journal of Experimental Medicine, vol. 235 (3), pp. 241–248. DOI: 10.1620/tjem.235.241
23. Iijima S. Late-onset glucocorticoid-responsive circulatory collapse in premature infants. Pediatr Neonatol, 2019, vol. 60 (6), pp. 603–610. DOI: 10.1016/j.pedneo.2019.09.005
24. Johnson P.J. Hydrocortisone for treatment of hypotension in the newborn. Neonatal Netw, 2015, vol. 34, p. 46e51.
25. Masumoto K., Tagawa N., Kobayashi Y., Kusuda S. Cortisol production in preterm infants with or without late-onset adrenal insufficiency of prematurity: a prospective observational study. Pediatr Neonatol, 2019, vol. 60, p. 504e11.
26. Arima M., Tsukamoto S., Fujiwara K. et al. Late-onset circulatory collapse and continuous positive airway pressure are useful predictors of treatment- requiring retinopathy of prematurity: a 9-year retrospective analysis. Sci Rep, 2017, vol. 7, p. 3904.
27. Verma R.P., Dasnadi S., Zhao Y., Chen H.H. A comparative analysis of ante- and postnatal clinical characteristics of extremely premature neonates suffering from refractory and non-refractory hypotension: Is early clinical differentiation possible? Early Hum Dev, 2017, vol. 113, pp. 49–54. DOI: 10.1016/j.earlhumdev.2017.07.010
28. Marinelli K.C., Lyden E.R., Peeples E.S. Clinical risk factors for the development of late-onset circulatory collapse in premature infants. Pediatr Res, 2021, vol. 89 (4), pp. 968–973. DOI: 10.1038/s41390-020-0990-7
29. Watterberg K.L. Hydrocortisone dosing for hypotension in newborn infants: less is more. J Pediatr, 2016, vol. 174, p. 23e6.
30. Peeples E.S. An evaluation of hydrocortisone dosing for neonatal refractory hypotension. J Perinatol, 2017, vol. 37, p. 943e6.
31. Zung A., Radi A., Almashanu S. The natural history of congenital hypothyroidism with delayed TSH elevation in neonatal intensive care newborns. Clin. Endocrinol, 2020, vol. 92, pp. 443–449. DOI: 10.1111/cen.14173
32. Chaudhari M., Slaughter J.L. Thyroid Function in the Neonatal Intensive Care Unit. Clin. Perinatol, 2018, vol. 45, pp. 19–30. DOI: 10.1016/j.clp.2017.10.005
33. Zdraveska N., Kocova M. Thyroid function and dysfunction in preterm infants- Challenges in evaluation, diagnosis and therapy. Clin Endocrinol (Oxf), 2021, vol. 95, pp. 556–570. Doi: 10.1111/cen.14481
34. Ahmad N., Irfan A., Al Saedi SA. Congenital hypothyroidism: Screening, diagnosis, management, and outcome. J Clin Neonatol, 2017, vol. 6, pp. 64–70.
35. Rai R., Singh D.K., Bhakhri B.K. Transient hypothyroxinemia of prematurity and its risk factors in an extramural neonatal intensive care unit. Arch Endocrinol Metab, 2021, vol. 65 (6), pp. 723–729. DOI: 10.20945/2359-3997000000360
36. Park E.S., Yoon J.Y. Factors associated with permanent hypothyroidism in infants with congenital hypothyroidism. BMC Pediatr, 2019, vol. 19 (1), p. 453. DOI: 10.1186/s12887-019-1833-8
37. Odenwald B., Fischer A., Röschinger W., Liebl B., Schmidt H. Nennstiel U.Long-Term Course of Hypothyroidism Detected through Neonatal TSH Screening in a Population-Based Cohort of Very Preterm Infants Born at Less than 32 Weeks of Gestation. Int J Neonatal Screen, 2021, vol. 7 (4), p. 65. DOI: 10.3390/ijns7040065
38. van Trotsenburg A.S., Stoupa A., Léger J., Rohrer T.R. et al. Congenital hypothyroidism: A 2020 consensus guidelines update an Endo-European reference network (ERN) initiative endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology. Thyroid, 2021, vol. 31, pp. 387–419. DOI: 10.1089/thy.2020.0333
39. Chung H.R. Screening and management of thyroid dysfunction in preterm infants. Ann. Pediatr. Endocrinol. Metab, 2019, vol. 24, pp. 15–21. DOI: 10.6065/apem.2019.24.1.15
40. Sharma J.D., Nazir M.F.H., Khan A.G., Hoque B. Does Hypothyroxinemia of Preterm Neonates Persist beyond 7 weeks of Life? Indian J. Pediatr, 2019, vol. 86, pp. 686–691.
41. Yoon S.A., Chang Y.S., Ahn S.Y. et al. Initial and delayed thyroid-stimulating hormone elevation in extremely low-birth-weight infants. BMC Pediatr, 2019, vol. 19, p. 347. DOI: 10.1186/s12887-019-1730-1
42. Kaluarachchi D.C., Allen D.B., Eickhoff J.C., Dawe S.J., Baker M.W. Thyroid-stimulating hormone reference ranges for preterm infants. Pediatrics, 2019, vol. 144 (2).
43. Grob F., van Vliet G. Avoiding the Overdiagnosis of Congenital Hypothyroidism in Premature Newborns. Pediatrics, 2019, vol. 144, p. e20191706. DOI: 10.1542/peds.2019-1706
44. Flores-Robles C.M., Roldan-Valadez E., Martínez-Cruz N. et al. Reference Percentiles and Changes over Time for Total Thyroxine in Preterm Infants: A Retrospective Cohort Study. Diagnostics, 2020, vol. 10, p. 475. DOI: 10.3390/diagnostics10070475
45. Hijman A.-I., Konrad D., Fingerhut R. Determining Reference Ranges for Total T4 in Dried Blood Samples for Newborn Screening. Int. J. Neonatal Screen, 2020, vol. 6, p. 17.
46. Bhatia V. Hypothyroxinemia in Preterm Neonates: Not Always Hypothyroidism. Indian J Pediatr, 2019, vol. 86 (8), pp. 671–672. DOI: 10.1007/s12098-019-03015-1
47. Osborn D.A., Hunt R.W. Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst. Rev, 2007, vol. 1, p. CD005948. DOI: 10.1002/14651858.CD005948.pub2
48. Van Vliet G., Grosse S.D. Newborn screening for congenital hypothyroidism and congenital adrenal hyperplasia: Benefits and costs of a successful public health program. Med Sci (Paris), 2021, vol. 37 (5), pp. 528–534. DOI: 10.1051/medsci/2021053
49. Williams F.L.R., Lindgren A., Watson J., Boelen A., Cheetham T. Thyroid function in preterm infants and neurodevelopment at 2 years. Arch. Dis. Child. Fetal Neonatal Ed, 2020, vol. 105, pp. 504–509. DOI: 10.1136/archdischild-2018-316742
50. Bongers-Schokking J.J., Resing W.C.M., Oostdijk W. et al. Relation between early over and under treatment and behavioural problems in preadolescent children with congenital hypothyroidism. Horm Res Pediatr, 2018, vol. 90, pp. 247–256.
51. Yoon S.A., Chang Y.S., Ahn S.Y., Sung S.I., Park W.S. Incidence and severity of transient hypothyroxinaemia of prematurity associated with survival without composite morbidities in extremely low birth weight infants. Sci Rep, 2019, vol. 9 (1), p. 9628.
52. Eerdekens A., Langouche L., van den Berghe G. Review shows that thyroid hormone substitution could benefit transient hypothyroxinaemia of prematurity but treatment strategies need to be clarified. Acta Pædiatrica, 2019, vol. 108 (5), pp. 792–805. DOI: 10.1111/apa.14685
53. Goel D., Luig M., Maheshwari R., D’Cruz D., Goyen T.A. General Movement assessment and neurodevelopmental trajectory in extremely preterm infants with hypothyroxinemia of prematurity (THOP). Early Hum Dev, 2020, vol. 144, p. 104886. DOI: 10.1016/j.earlhumdev.2019.104886
54. Tan L.O., Tan M.G., Poon W.B. Correction: Lack of association between hypothyroxinemia of prematurity and transient thyroid abnormalities with adverse long term neurodevelopmental outcome in very low birth weight infants. PLoS One, 2019, vol. 14, p. e0223867.
55. Lin Y.-C., Wang C.-Y., Pan Y.-W., Chen Y.-J. et al. Postnatal Serum Total Thyroxine of Very Preterm Infants and Long-Term Neurodevelopmental Outcome. Nutrients, 2021, vol. 13, p. 1055. Doi: 10.3390/nu13041055
56. Iijima Sh. Current knowledge of transient hypothyroxinemia of prematurity: to treat or not to treat? The Journal of Maternal-Fetal & Neonatal Medicine, vol. 32 (15), pp. 2591–2597. DOI: 10.1080/14767058.2018.1441277
57. Klinicheskie rekomendatsii “Diagnostika i lechenie vrozhdennogo gipotireoza” [Clinical guidelines “Diagnostics and treatment of congenital hypothyroidism”], 2020.